Insider Transactions in Q2 2021 at Oak Street Health, Inc. (OSH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.41%
|
$1,350,000
$60.93 P/Share
|
|
Jun 22
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.88%
|
$2,950,000
$59.42 P/Share
|
|
Jun 17
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.38%
|
$330,512
$56.48 P/Share
|
|
Jun 16
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Bona fide gift
|
Direct |
21,100
-0.55%
|
-
|
|
Jun 16
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
17,600
-0.22%
|
-
|
|
Jun 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.62%
|
$6,126,400
$56.14 P/Share
|
|
Jun 08
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.43%
|
$1,450,000
$58.79 P/Share
|
|
Jun 03
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.28%
|
$354,120
$60.06 P/Share
|
|
Jun 01
2021
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.81%
|
$600,000
$60.86 P/Share
|
|
Jun 01
2021
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
4,791,569
-10.58%
|
$297,077,278
$62.0 P/Share
|
|
Jun 01
2021
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
7,260,689
-10.58%
|
$435,641,340
$60.14 P/Share
|
|
May 27
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.27%
|
$1,350,000
$60.82 P/Share
|
|
May 25
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.22%
|
$1,550,000
$62.88 P/Share
|
|
May 21
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
22,410
-0.76%
|
$1,411,830
$63.61 P/Share
|
|
May 20
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.22%
|
$365,924
$62.17 P/Share
|
|
May 20
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
65,478
-2.18%
|
$4,125,114
$63.19 P/Share
|
|
May 13
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.31%
|
$6,126,400
$56.1 P/Share
|
|
May 11
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.21%
|
$1,350,000
$54.39 P/Share
|
|
May 06
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.22%
|
$330,512
$56.42 P/Share
|
|
May 05
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+48.28%
|
-
|
|
May 04
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.15%
|
$2,950,000
$59.49 P/Share
|
|
May 03
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
12,112
-0.4%
|
$763,056
$63.27 P/Share
|
|
Apr 30
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
65,332
-2.11%
|
$3,919,920
$60.95 P/Share
|
|
Apr 29
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.79%
|
$1,372,500
$61.54 P/Share
|
|
Apr 29
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
125,068
-3.88%
|
$7,629,148
$61.72 P/Share
|
|
Apr 28
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
109,600
-2.31%
|
$6,795,200
$62.34 P/Share
|
|
Apr 27
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
125,000
-1.21%
|
$7,625,000
$61.35 P/Share
|
|
Apr 22
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.27%
|
$348,218
$59.97 P/Share
|
|
Apr 22
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,974
-0.34%
|
$1,650,466
$59.98 P/Share
|
|
Apr 21
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,026
-0.15%
|
$709,534
$59.95 P/Share
|
|
Apr 20
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.3%
|
$2,900,000
$58.71 P/Share
|
|
Apr 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.6%
|
$6,235,800
$57.81 P/Share
|
|
Apr 15
2021
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.53%
|
$570,000
$57.87 P/Share
|
|
Apr 12
2021
|
Timothy M Cook Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,770
+1.16%
|
-
|
|
Apr 12
2021
|
Brian Clem Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,416
+2.09%
|
-
|
|
Apr 12
2021
|
Robert Guenthner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,708
+1.21%
|
-
|
|
Apr 08
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.18%
|
$365,924
$62.14 P/Share
|